Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study

BACKGROUND: The iron-based phosphate binder (PB), sucroferric oxyhydroxide (SFOH), is indicated to control serum phosphorus levels in patients with chronic kidney disease on dialysis. METHODS: This non-interventional, prospective, multicentre, cohort study conducted in seven European countries evalu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Kidney J
Autors principals: Vervloet, Marc G, Boletis, Ioannis N, de Francisco, Angel L M, Kalra, Philip A, Ketteler, Markus, Messa, Piergiorgio, Stauss-Grabo, Manuela, Derlet, Anja, Walpen, Sebastian, Perrin, Amandine, Ficociello, Linda H, Rottembourg, Jacques, Wanner, Christoph, Cannata-Andía, Jorge B, Fouque, Denis
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8243278/
https://ncbi.nlm.nih.gov/pubmed/34221384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfaa211
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars